Pelvic Inflammatory Disease: Clinical Trials

9 trials for Pelvic Inflammatory Disease, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 completed, 3 unknown, 1 recruiting, 1 terminated. 9 Phase 2, 2 Phase 1, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 29Completed 4, Unknown 3, Recruiting 1, Terminated 1
Phase 12Completed 1, Recruiting 1
Phase 31Completed 1

Follow Pelvic Inflammatory Disease: new trials by email Literature Review of Pelvic Inflammatory Disease trials Research Report on Pelvic Inflammatory Disease

Trials (filtered) newest first · largest first

All 9 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Assessing the Mechanisms and Impact of a Novel Cannabinoid Product for Gynecologic Pain
Custom-formulated, high-CBD study product, Placebo - Endometriosis, Adenomyosis
Phase 1 / Phase 2RecruitingStaci Gruber, Ph.D.602026-09-012026-07-27
Efficacy and Safety of Fuke Qianjin Capsule in Patients With Pelvic Inflammatory Diseases
Control Group, Test Group - Pelvic Inflammatory Disease
Phase 2CompletedUniversity of Karachi1982021-09-212023-04-04
Two-drug Antibiotic Prophylaxis in Scheduled Cesarean Deliveries
Azithromycin 500 mg, Mefoxin 2g - Endometritis, Cesarean Section; Infection
Phase 2UnknownRWJ Barnabas Health at Jersey City Medical Center8002019-09-152019-09-17
Comparative Study on the Efficacy of Ovarian Stimulation Protocols on the Success Rate of ICSI in Female Infertility
Human Chorionic Gonadotropin (hCG), Gonadotropins, GNRH-A Triptorelin - Female Infertility, Female Infertility Due to Ovulatory Disorder
Phase 1 / Phase 2CompletedLebanese University2002018-02-012023-05-09
Clinical Research of TCM on Pelvic Inflammatory Disease Sequelae
Comprehensive treatment of TCM, Expectant treatment - Pelvic Inflammatory Disease
Phase 2UnknownShanghai University of Traditional Chinese Medicine1752016-11-012016-11-23
The Optimal Time for Intravenous Antibiotic Prophylaxis in Elective Cesarean Section
ceftriaxone - Endometritis
Phase 2UnknownCairo University6002016-04-012016-04-19
The Importance of Anti-anaerobic Therapy for Acute Pelvic Inflammatory Disease (PID)
Ceftriaxone, Doxycycline, Metronidazole - Pelvic Inflammatory Disease
Phase 2CompletedHarold Wiesenfeld2332010-11-012018-07-10
Antibiotic Prophylaxis in Prelabor Rupture of Membranes at Term
Ampicillin + gentamicin - Chorioamnionitis, Puerperal Endometritis
Phase 2 / Phase 3CompletedHospital de Santa Maria, Portugal1612008-10-012016-11-28
The Impact of Treating Minor Uterine Cavity Abnormalities Diagnosed by Office Hysteroscopy in Unselected In Vitro Fertilization (IVF) Cases
Treatment of predefined abnormality by hysteroscopic surgery, Ofloxacinum/Doxycycline - Minor Intra-uterine Abnormalities
Phase 2TerminatedUMC Utrecht7002007-06-012015-06-04

Narrower conditions

Endometritis (5)  ·  Endometriosis (2)  ·  Adenomyosis (1)  ·  Chorioamnionitis (1)  ·  Fetal Membranes, Premature Rupture (1)  ·  Infections (1)  ·  Infertility (1)  ·  Infertility, Female (1)  ·  Leiomyoma (1)  ·  Myoma (1)  ·  Neonatal Sepsis (1)  ·  Polycystic Ovary Syndrome (1)  ·  Polyps (1)  ·  Pregnancy, Ectopic (1)

Broader conditions

Adnexal Diseases (9)  ·  Female Urogenital Diseases (9)  ·  Female Urogenital Diseases and Pregnancy Complications (9)  ·  Genital Diseases (9)  ·  Genital Diseases, Female (9)  ·  Urogenital Diseases (9)  ·  Uterine Diseases (6)  ·  Infections (5)  ·  Pelvic Infection (4)  ·  Neoplasms (2)  ·  Neoplasms by Histologic Type (2)  ·  Neoplasms, Connective and Soft Tissue (2)  ·  Neoplasms, Muscle Tissue (2)  ·  Pathologic Processes (2)

Interventions

Ceftriaxone (2)  ·  Doxycycline (2)  ·  Ampicillin (1)  ·  Azithromycin (1)  ·  Cefoxitin (1)  ·  Chorionic Gonadotropin (1)  ·  Control Groups (1)  ·  Gentamicins (1)  ·  Gonadotropins (1)  ·  LHRH, Ac-Nal(1)-Cpa(2)-Trp(3)-Arg(6)-Ala(10)- (1)  ·  Medicine, Chinese Traditional (1)  ·  Menotropins (1)  ·  Metronidazole (1)  ·  Ofloxacin (1)  ·  Oral Medicine (1)

Sponsors

Cairo University (1)  ·  Harold Wiesenfeld (1)  ·  Hospital de Santa Maria, Portugal (1)  ·  Lebanese University (1)  ·  RWJ Barnabas Health at Jersey City Medical Center (1)  ·  Shanghai University of Traditional Chinese Medicine (1)  ·  Staci Gruber, Ph.D. (1)  ·  UMC Utrecht (1)  ·  University of Karachi (1)

Countries

United States (3)  ·  China (1)  ·  Lebanon (1)  ·  Netherlands (1)  ·  Pakistan (1)  ·  Portugal (1)

Top investigators

Filipa Faria Vaz Passos, Dr (1)  ·  Frank JM Broekmans, Dr. (1)  ·  Harold C Wiesenfeld, MD (1)  ·  Human M Fatemi, Dr. (1)  ·  Jenneke C Kasius (1)  ·  Moutaz Elsherbini, MD (1)  ·  Nehman Makdissy, Professor (1)  ·  Paul Devroey, Prof. dr. (1)  ·  Professor Dr. Muhammad Raza Shah (1)  ·  Samar El Hamoui, Dr (1)  ·  Tali Wajsfeld, MD (1)

Results publications

PMID 23090521, PMID 23499151, PMID 32052831, PMID 38584600

NIH funding

U19AI084024 (1)